İsmi Onur, Yildirim Veli, Vayisoglu Yusuf, Togrul Anis, Toros Fevziye, Unal Murat
Department of Otorhinolaryngology, Mersin Üniversitesi, Mersin, Turkey.
Department of Child and Adolescent Psychiatry Mersin Üniversitesi, Mersin, Turkey.
Int Arch Otorhinolaryngol. 2018 Jul;22(3):220-224. doi: 10.1055/s-0037-1605367. Epub 2017 Aug 7.
There has been a sudden idiopathic hearing loss case presented after methylphenidate treatment in a child with attention deficit hyperactivity disorder (ADHD). This study was performed to reveal the probable ototoxic side effects of methylphenidate use in patients with ADHD. Thirty pediatric patients with ADHD were included in the study. Pure tone audiometry, speech discrimination scores, waves I, III, V absolute latencies and waves I-III, I-V, III-V interpeak latencies at the 80 dB nHL intensity after click stimulus auditory brainstem response (ABR) results were compared before and 3 months after methylphenidate treatment. There were no statistically significant difference between pretreatment and posttreatment pure tone and speech audiometry findings and ABR results (p > 0.05 for all parameters). Methylphenidate can be regarded as a safe drug regarding ototoxic side effects. Additional studies with a larger sample size and longer follow-up may be needed.
一名患有注意力缺陷多动障碍(ADHD)的儿童在使用哌甲酯治疗后出现了突发性特发性听力损失病例。本研究旨在揭示哌甲酯在ADHD患者中可能存在的耳毒性副作用。30名患有ADHD的儿科患者被纳入研究。比较了哌甲酯治疗前和治疗3个月后在80 dB nHL强度下短声刺激听性脑干反应(ABR)结果中的纯音听力测定、言语辨别分数、波I、III、V绝对潜伏期以及波I-III、I-V、III-V峰间潜伏期。治疗前和治疗后的纯音和言语听力测定结果以及ABR结果之间无统计学显著差异(所有参数p>0.05)。就耳毒性副作用而言,哌甲酯可被视为一种安全的药物。可能需要进行更大样本量和更长随访时间的进一步研究。